Company Profile

Samsung Epis Holdings Co., Ltd., a biotechnology company, manage the portfolio of biopharmaceutical products. The company was founded in 2025 and is based in Incheon, South Korea.

Latest News

Kenvue’s Tylenol with Naproxen gains FDA approval

Pharmaceutical Technology • 07/27/2026

Bernstein Adjusts PT on Verizon Communications to $47 From $44, Maintains Market Perform Rating

MT Newswires • 07/27/2026

3 Stocks For Latin America’s Renewable Power Boom

Barrons.com • 07/27/2026

Cloudbeds rolls out data intelligence tool for hotel groups

Hotel Management Network • 07/27/2026

Mizuho Adjusts Price Target on Advanced Micro Devices to $625 From $615, Maintains Outperform Rating

MT Newswires • 07/27/2026